Cosmos Health

Cosmos Health EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cosmos Health (COSM) as of Oct 17, 2026 is -16.52 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -13.92 M USD — a change of 18.68% (lower).

EBITDA

-16.52 MUSD

YoY

18.68%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cosmos Health is 2025 -16.52 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cosmos Health was 2024 -13.92 M USD. It decreases by 18.68% lower compared to the previous year.

The Cosmos Health EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-2.20 M USD
Jan 1, 2019
-993,213.00 USD
Jan 1, 2020
3.11 M USD
Jan 1, 2021
-4.08 M USD
Jan 1, 2022
-7.28 M USD
Jan 1, 2023
-21.22 M USD
Jan 1, 2024
-13.92 M USD
Jan 1, 2025
-16.52 M USD
The Cosmos Health EBITDA history
YEAREBITDAYoY
-16.52 MUSD+18.68%
-13.92 MUSD-34.38%
-21.22 MUSD+191.28%
-7.28 MUSD+78.38%
-4.08 MUSD-231.12%
3.11 MUSD-413.56%
-993,213.00USD-54.76%
-2.20 MUSD-51.63%
-4.54 MUSD+1,081.47%
-384,217.00USD-11.16%
-432,459.00USD-106.07%
7.13 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cosmos Health Stock analysis

What does Cosmos Health do? Cosmos Health Inc., headquartered in Chicago, Illinois, operates in the Health Care sector, specializing in the importation, exportation, distribution, and sale of branded pharmaceuticals, over-the-counter medicines, and generic pharmaceuticals. The company, listed on 19 May 2010, employs 163 full-time staff. Through its subsidiary Amplerissimo Ltd., it provides consulting services including data analysis, marketing management, and business software consulting. Amplerissimo's subsidiary SkyPharm S.A. trades pharmaceutical products across the European Union. Cosmos Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cosmos Health stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cosmos Health is -16.52 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cosmos Health changed from -13.92 M USD to -16.52 M USD, representing a 18.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Cosmos Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Cosmos Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cosmos Health

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cosmos Health